Neuronetics, Inc.
STIM
Rank in Stocks
#17501
Neuronetics, Inc. functions as a medical technology enterprise with... Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.
Share Price
$2.18
Last synced: 2026-11-09
Market Cap
$166.11M
Change (1 day)
1.40%
Change (1 year)
-0.91%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Neuronetics, Inc. (STIM)
Category
Healthcare
EPS for Neuronetics, Inc. (STIM)
EPS as of September 2026 TTM: $-0.32
According to Neuronetics, Inc.'s latest financial reports, its current EPS (TTM) is $-0.32. At the end of 2025 the company had an EPS of $-0.59, an increase over its 2024 EPS of $-1.38.
EPS history for Neuronetics, Inc. from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.32 | -45.76% |
| 2025 | $-0.59 | -57.25% |
| 2024 | $-1.38 | 31.43% |
| 2023 | $-1.05 | -23.91% |
| 2022 | $-1.38 | 13.11% |
| 2021 | $-1.22 | -16.44% |
| 2020 | $-1.46 | -21.93% |
| 2019 | $-1.87 | -30.48% |
| 2018 | $-2.69 | -99.81% |
| 2017 | $-1.43K | 42.95% |
| 2016 | $-1.00K | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -943.75% |
US
|
|
| $4.09 | -1,378.13% |
IE
|
|
| $9.45 | -3,053.13% |
US
|
|
| $2.37 | -840.63% |
US
|
|
| $1.77 | -653.13% |
US
|
Questions about Neuronetics, Inc.'s earnings per share (EPS)
What is Neuronetics, Inc.'s earnings per share (EPS)?
Neuronetics, Inc.'s earnings per share (EPS) over the last twelve months is $-0.32, as of Sep 2026.
What was Neuronetics, Inc.'s earnings per share (EPS) in 2025?
In 2025, Neuronetics, Inc.'s earnings per share (EPS) was $-0.59, compared with $-1.38 in 2024.
How has Neuronetics, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Neuronetics, Inc.'s earnings per share (EPS) was highest in 2025 ($-0.59) and lowest in 2020 ($-1.46).
How does Neuronetics, Inc.'s earnings per share (EPS) compare with similar companies?
Neuronetics, Inc.'s earnings per share (EPS) ($-0.32) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.